21 December 2010 /Retail and online sale
The pharmaceutical company Missionpharma A/S has alerted the Danish Medicines Agency that an illegal version of the medicine Pregnyl is in circulation.
21 December 2010 /News - medical devices
The Danish Medicines Agency will be sending out acknowledgement letters and decisions to companies, researchers, etc. electronically, in so far as we have a registered email address for the person(s) that we primarily correspond with
20 December 2010 /Product areas
Older versions of el-scooters (Model T and Model Nordic) could have problems with the electronics and therefore need to be adjusted.
17 December 2010 /Authorisation and supervision
The European Directorate for the Quality of Medicines and Healthcare, EDQM, has suspended the following Certificate og Suitability. CEP R1-1998-070-Rev02 Pyrazinamide
17 December 2010 /News - miscellaneous
Recommendation for doctors and dialysis patients in connection with peritoneal dialysis solutions from Baxter A/S
The European Medicines Agency (EMA) recommends that all batches of Baxter's peritoneal dialysis solutions, Extraneal®, Nutrineal® and Dianeal® be replaced.
16 December 2010 /News - miscellaneous
The Danish Veterinary and Food Administration and the Danish Medicines Agency only found a small number of violations of the Danish Food Act and the Danish Medicines Act during a joint on-site inspection of some 30 fitness centres and clubs in autumn 2010.
14 December 2010 /Product information
The Danish Medicines Agency strongly warns against using the potency-enhancing product marketed as POWERtabs based on information from the Norwegian drug regulatory authorities that a Norwegian man needed treatment after having taken the potency-enhancing product.
13 December 2010 /Side effects and trials
Exercise particular caution when using Extraneal Viaflex® and Nutrineal Viaflex® peritoneal dialysis solution
A number of units of Baxter’s peritoneal dialysis solution of the brands Extraneal® and Nutrineal® manufactured in Ireland are suspected of containing a too high content of endotoxin. A too high content of endotoxin may pose a risk of aseptic peritonitis (infection of abdominal fluid).
10 December 2010 /Side effects and trials
We are updating the validation rules in connection with the implementation of the Danish Medicines Agency's new adverse reaction database. The changes, which entered into force on 6 December 2010, are.
02 July 2010 | Updated 10 December 2010 /Retail and online sale
In consultation with the Licensing Committee, the Danish Medicines Agency has adopted a new practice, describing when an over-the-counter (OTC) medicine is released for sale outside pharmacies.
06 December 2010 /About us
The Danish Medicines Agency will be sending out acknowledgement letters and decisions to companies, researchers, etc. electronically, in so far as we have registered email address for the person(s) that we primarily correspond with.